PLA2G16 expression predicts prognosis and gemcitabine sensitivity in patients with pancreatic cancer
Elevated PLA2G16 expression is associated with poor survival and gemcitabine resistance in pancreatic cancer, making it a potential prognostic marker and therapeutic target.
Authors
- Xiaoyu Sun (ORCID: https://orcid.org/0000-0002-9468-8787)
- Haiyang Jiang (ORCID: https://orcid.org/0000-0002-0529-0719)
- Xinbing Sui (ORCID: https://orcid.org/0000-0001-7330-0467)
- Yucheng Zhou (ORCID: https://orcid.org/0000-0003-3856-0807)
- Jing Xia
- Xueni Sun (ORCID: https://orcid.org/0000-0001-9958-2634)
- Yufei Huang (ORCID: https://orcid.org/0000-0001-5432-8181)
- Jie Gu (ORCID: https://orcid.org/0009-0009-0709-5237)
Institutions
- Hangzhou Normal University (CN)
- Zhejiang Provincial People's Hospital (CN)
Publication Details
- Journal
- PeerJ
- Published
- 2025-05-30
- DOI
- https://doi.org/10.7717/peerj.19517
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00